Ending AIDS as a public health threat by 2030 is still within reach, but it demands a decisive revival of partnership models, sustained community leadership and unwavering financial commitment from the United Kingdom.
The Global Fund’s Milestones and Current Reach
When the United Kingdom helped launch the Global Fund in 2002, only 102,000 individuals worldwide were receiving antiretroviral therapy, representing less than one percent of those living with HIV. Fast‑forward to the most recent reporting period and the picture has transformed dramatically: 26.9 million people in Global Fund‑supported countries now have access to life‑saving treatment, and AIDS‑related deaths have fallen by 57 percent since 2010, dropping from 1.3 million to 570,000 in 2025.
Funding Cuts Threaten Gains
Despite these achievements, the financial environment is under severe strain. Donor governments collectively reduced HIV‑specific funding by $2.1 billion (£1.6 billion) in 2025, a 25 percent decline from the previous year. The cutbacks have hit prevention programmes hardest, and women bear the brunt of the fallout. In sub‑Saharan Africa, women now account for six out of ten new infections, while adolescent girls and young women aged 15‑24 continue to face a staggering 3,000 new cases each week in 2025. The United Kingdom’s own contribution to official development assistance was trimmed to 0.3 percent of gross national income last year, raising doubts about its global leadership in health.
Innovation, Community Leadership and Human Rights
Progress hinges on the rapid scale‑up of breakthrough tools such as lenacapavir, a twice‑yearly injectable that provides potent pre‑exposure prophylaxis, and on the full participation of community‑driven organisations. Unfortunately, the recent funding reductions have slashed the output of these grassroots groups by roughly half, undermining essential prevention and support services for people living with HIV. At the same time, a concerning regression in human‑rights protections is emerging, with the criminalisation of marginalised communities on the rise for the first time since UNAIDS began monitoring such trends.
UK Leadership Must Re‑Engage
Minister for International Development and Africa Kirsty McNeill emphasised that the United Kingdom’s approach is centred on partnership rather than hierarchy, arguing that combining diverse strengths yields results far beyond what any single nation could achieve alone. To keep the 2030 target alive, the UK must restore confidence through predictable, generous funding and by championing community‑led solutions on the world stage. Scientific advances must be made affordable and accessible across low‑ and middle‑income countries, ensuring that innovations like lenacapavir reach those who need them most.
Why it Matters
The trajectory of the global HIV response illustrates how collaborative, rights‑based programming can turn a once‑deadly epidemic into a manageable public‑health challenge. Yet the current wave of funding cuts and rights‑related rollbacks threatens to reverse decades of progress, particularly for women and young people who are already disproportionately affected. The United Kingdom’s political and financial commitment will be a decisive factor in whether the world stays on track to consign AIDS to history or watches the disease re‑emerge as a major public‑health threat.
